Products
Services
Applications
Resources Get started

LamPORE is an expanding product range, enabling rapid and highly scalable pathogen detection.  

The first LamPORE assay, LamPORE COVID-19, is now CE marked for in vitro diagnostic use for the detection of the SARS-CoV-2 virus, using the GridION device.

The LamPORE development pipeline includes portable analysis using the MinION Mk1C device, multi respiratory panel virus detection, and RNA extraction-free methodologies. 

Visit the LamPORE website to find out more:

LamPORE COVID-19

 

Open a chat to talk to our sales team
FAQs

FAQs

Search